Mibanco: Meeting the Mainstreaming of Microfinance (MM)

Michael  Chu; Gustavo   Herrero; Jean  Hazell

Case | HBS Case Collection | August 2011

Mibanco: Meeting the Mainstreaming of Microfinance (MM)

by Michael Chu, Gustavo Herrero and Jean Hazell

Abstract

Facing an increasingly competitive microfinance market in Peru, Mibanco must continually optimize its product offerings, marketing operations, and human resource management to stay on top. This multimedia courseware provides visual orientation to enable viewers to more fully understand the nature of microentrepreneurs and the microfinance market in Peru, as well how Mibanco attracts and retains clients, balances efficiency and risk management in its loan portfolio, and works to build an organization capable of sustaining rapid growth. The courseware includes five video segments: Introduction, Competition, Marketing, Operations and Human Resources, with a total run time of 52 minutes.

Keywords: Microfinance; Markets; Change; Problems and Challenges; Management Teams; Employees; Marketing; Operations; Human Resources; Financial Services Industry; Peru;

Format: Multimedia

1 pages

Educators Purchase

Citation:

Chu, Michael, Gustavo Herrero, and Jean Hazell. "Mibanco: Meeting the Mainstreaming of Microfinance (MM)." Harvard Business School Multimedia/Video Case 310-701, August 2011.

In 2009, Dan Meyer and Richard Palmer, two veterans of the fast-moving consumer goods (FMCG) industry, founded Nehemiah Manufacturing to build FMCG brands while providing jobs to Cincinnati, Ohio’s beleaguered urban core. Two years later, the pair made their first “second-chance” hire of a convicted felon, a successful experiment that would grow to define the company. By 2019, Nehemiah’s factory floor, as well as several supervisory and management positions, would be staffed by ex-offenders. With a robust net of social support services and a non-profit foundation for training peer companies in how to hire second-chance employees, Meyer and Palmer advocated using second-chance hiring to decrease turnover and create staff loyalty. This case deals with the challenges and opportunities associated with growing a manufacturing company while prioritizing a social mission and enables students to evaluate the potential of second-chance hiring programs.

After long dominating Mexican microfinance, Compartamos Banco faces the emergence of fintech, just as for the first time its loan portfolio and clients have declined. Enrique Majós, CEO of GENTERA, the bank´s parent company, is keenly aware of the profound changes since the Compartamos IPO in April 2007, when it was valued at $1.5 billion and became the first bank wholly dedicated to microfinance to be quoted in a major stock exchange. Since then, the market has become intensely competitive, with both large established institutions and new entrants vying for the same customers. Simultaneously, the digital era has spawned fintech, threatening to disrupt Compartamos’ highly successful model but also providing opportunities for the bank to reshape it. While challenged to manage key innovation within a leading incumbent, Majós must consider whether to commit his team to a major cost reduction in the next few years to his board of directors at their next meeting at the end of the month.

With a breakthrough cure for Hepatitis C listing in the U.S. at $1,000/pill, Gilead must now solve the issue of making it available to patients across the world, much as it did for its blockbuster HIV/AIDS antiretrovirals. For Erik Musalem, the new general manager of Gilead Mexico, the challenge was complicated by operating in a middle-income country, where Gilead’s terms for more vulnerable nations did not apply. For all practical purposes, Musalem had only one customer for his company’s Hep C medicine: Mexico’s public health system and the National Pricing Commission that set prices annually for the entire sector. With no lack of priorities competing for the finite resources of the public health sector, Musalem’s charge was to devise the strategy that in the long run would maximize access to the cure in Mexico while protecting the financial strength of Gilead Sciences, Inc.

Faculty & Research

Mibanco: Meeting the Mainstreaming of Microfinance (MM)

Abstract

Citation:

About the Author

More from the Author